The Human Platelet Lysate (HPL) market is expected to experience significant growth in 2024, driven by increasing demand for advanced regenerative medicine therapies and the growing use of HPL in cell culture media. HPL, a blood-derived product that offers a rich source of growth factors and cytokines, is gaining popularity for its ability to support cell proliferation and tissue regeneration in various therapeutic applications. Key Factors Driving Market Growth One of the primary factors driv...